Lenvatinib Capsules contain Lenvatinib Mesylate as the active ingredient. It is a targeted anti-cancer medicine that belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs).
Lenvatinib works by blocking certain proteins (VEGFR, FGFR, PDGFR, KIT, RET) that promote cancer cell growth and the formation of new blood vessels, thereby slowing down or stopping the spread of cancer cells.
Lenvatinib 4mg & 10mg Capsules are prescription anticancer medicines used in specific treatment regimens for certain thyroid, liver, and kidney cancers. The appropriate dose and combination therapy depend on the individual patient's condition. Always use Lenvatinib exactly as directed by your oncologist or healthcare provider.